Oncogene products and other diagnostic markers in human breast cancer patients: Treatment effects and their significance

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 403-411

  Dowsett, M ^a,b   Makris, A ^a,b   Ellis, P ^a,b   Johnston, S R D ^a,b   Salter, J ^a,b   Detre, S ^a,b   Humphries, S ^a,b   Saccani Jotti, G ^a,b   Powles, T J ^a,b   Smith, I E ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FLUOROURACIL; GENE PRODUCT; HORMONE; METHOTREXATE; PROTEIN BCL 2; TAMOXIFEN;

APOPTOSIS; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CELL PROLIFERATION; CONFERENCE PAPER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NONHUMAN; ONCOGENE; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029974759     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16254.x     Document Type: Article

References (11)

1. DEFRIEND, D. J., A. HOWELL, R. I. NICHOLSON, E. ANDERSON, M. DOWSETT, R. E. MANSEL, R. W. BLAMEY, N. J. BUNDRED, J. F. ROBERTSON, C. SAUNDERS, M. BAUM, P. WALTON, F. SUTCLIFFE & W. E. WAKELING. 1994. Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res. 54: 408-414.
2. JOHNSTON, S. R. D., K. A. MACLENNAN, N. P. M. SACKS, J. SALTER, I. E. SMITH & M. DOWSETT. 1994. Modulation of bcl-2 and Ki67 expression in estrogen-receptor-positive human breast cancer by tamoxifen. Eur. J. Cancer 30A(11): 1663-1669.
3. DOWSETT, M., S. R. D. JOHNSTON, S. DETRE, J. SALTER, S. HUMPHRIES, G. SACCANI-JOTTI, I. E. SMITH, K. MACLENNAN & P. TROTT. 1994. Cytological evaluation of biological variables in breast cancer patients undergoing primary medical treatment. In Sex Hormones and Antihormones in Endocrine-dependent Pathology: Basic and Clinical Aspects. M. Motta & M. Serio, Eds.: 329-336. Elsevier. Amsterdam/ New York.
4. NEWBY, J. C., R. A'HERNE, R. D. LEE, I. E. SMITH, A. L. HARRIS & M. DOWSETT. 1995. Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand binding assay and clinical relevance in breast cancer. Br. J. Cancer. In press.
5. FERNANDO, I. N., J. TITLEY, T. J. POWLES, M. DOWSETT, P. A. TROTT, S. E. ASHLEY, H. T. FORD & M. G. ORMEROD. 1994. Measurement of S-phase fraction and ploidy in sequential fine needle aspirates from primary human breast tumours treated with tamoxifen. Br. J. Cancer 70: 1211-1216.
6. DOWSETT, M., S. R. D. JOHNSTON, J. NEWBY, M. GOLDING, N. SACKS & I. E. SMITH. 1995. Mechanisms of hormone response: a role for apoptosis. Endocr. Related Cancer 2: 3-11.
7. CLARKE, R. B., L. J. LAIDLAW, L. J. JONES, A. HOWELL & E. ANDERSON. 1993. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. Br. J. Cancer 67: 606-611.
8. SUTHERLAND, R. L., R. R. REDDEL & D. GREEM. 1983. Effects of estrogens on cell proliferation and cell cycle kinetics: a hypothesis on the cell cycle effects of antiestrogens. Eur. J. Cancer Clin. Oncol. 19: 307-318.
9. HICKMAN, J. A. 1992. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 1: 121-139.
10. WIJSMAN, J. H., R. R. JONKER, R. KEIJZER, C. J. H. VAN DE VELDE, C. J. CORNELLISSE & J. H. VAN DIERENDONCK. 1993. A new method to detect apoptosis in paraffin sections: in situ end-labelling of fragmented DNA. J. Histochem. Cytochem. 41: 7-12.
11. LIPPONEN, P., S. AALTOMAA, V-M. KOSMA & K. SYJANEN. 1994. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur. J. Cancer 30A: 2068-2073.